Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by 3d Analysis Group

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • 3d Analysis Group1
  • Cognitivebehavioral Treatment1
  • Attention And Lifestyle Counseling1
  • Manual Analysis Cohort1

Active Sponsors

  • Lourens A. Du Preez1
  • UConn Health1
  • Dr. Dean Reeves Clinic1

Top Investigators

Related Conditions

  • Myofascial Pain Dysfunction Syndrome1
  • Orofacial Pain1

Activity Timeline